Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy

Given the extreme importance of the current pandemic caused by COVID-19 and due to the fact that scientists agree that there is no identified treatment, this paper analyzes in detail the treatment of a severe COVID-19 patient with convalescent plasma and drugs based on current guidelines for COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Zhang, Yang, Yu, Qian, Zhu, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327103/
https://www.ncbi.nlm.nih.gov/pubmed/32670071
http://dx.doi.org/10.3389/fphar.2020.00966
_version_ 1783552473573621760
author Wang, Ying
Zhang, Yang
Yu, Qian
Zhu, Kun
author_facet Wang, Ying
Zhang, Yang
Yu, Qian
Zhu, Kun
author_sort Wang, Ying
collection PubMed
description Given the extreme importance of the current pandemic caused by COVID-19 and due to the fact that scientists agree that there is no identified treatment, this paper analyzes in detail the treatment of a severe COVID-19 patient with convalescent plasma and drugs based on current guidelines for COVID-19 diagnosis and treatment. This can provide a reference for other medical institutions on rational drug use and pharmaceutical care for severe COVID-19 patients.
format Online
Article
Text
id pubmed-7327103
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73271032020-07-14 Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy Wang, Ying Zhang, Yang Yu, Qian Zhu, Kun Front Pharmacol Pharmacology Given the extreme importance of the current pandemic caused by COVID-19 and due to the fact that scientists agree that there is no identified treatment, this paper analyzes in detail the treatment of a severe COVID-19 patient with convalescent plasma and drugs based on current guidelines for COVID-19 diagnosis and treatment. This can provide a reference for other medical institutions on rational drug use and pharmaceutical care for severe COVID-19 patients. Frontiers Media S.A. 2020-06-24 /pmc/articles/PMC7327103/ /pubmed/32670071 http://dx.doi.org/10.3389/fphar.2020.00966 Text en Copyright © 2020 Wang, Zhang, Yu and Zhu http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Ying
Zhang, Yang
Yu, Qian
Zhu, Kun
Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy
title Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy
title_full Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy
title_fullStr Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy
title_full_unstemmed Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy
title_short Convalescent Plasma Coupled With Medications for the Treatment of a Severe COVID-19 Patient: Drugs Analysis and Pharmaceutical Care Based on the Newly Established Guidelines for COVID-19 Remedy
title_sort convalescent plasma coupled with medications for the treatment of a severe covid-19 patient: drugs analysis and pharmaceutical care based on the newly established guidelines for covid-19 remedy
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327103/
https://www.ncbi.nlm.nih.gov/pubmed/32670071
http://dx.doi.org/10.3389/fphar.2020.00966
work_keys_str_mv AT wangying convalescentplasmacoupledwithmedicationsforthetreatmentofaseverecovid19patientdrugsanalysisandpharmaceuticalcarebasedonthenewlyestablishedguidelinesforcovid19remedy
AT zhangyang convalescentplasmacoupledwithmedicationsforthetreatmentofaseverecovid19patientdrugsanalysisandpharmaceuticalcarebasedonthenewlyestablishedguidelinesforcovid19remedy
AT yuqian convalescentplasmacoupledwithmedicationsforthetreatmentofaseverecovid19patientdrugsanalysisandpharmaceuticalcarebasedonthenewlyestablishedguidelinesforcovid19remedy
AT zhukun convalescentplasmacoupledwithmedicationsforthetreatmentofaseverecovid19patientdrugsanalysisandpharmaceuticalcarebasedonthenewlyestablishedguidelinesforcovid19remedy

Ejemplares similares